Martin Shkreli’s Old Pharma Company Faces Shareholder Battle

...ment Daraprim to $750 a pill from $17.50 after obtaining the exclusive rights to it in 2015. In December, the Federal Trade Commission accused Shkreli in court of using anticompetitive tactics to drive up the price of Da...
Read Full Article